Inovio Pharmaceuticals Inc - Company Profile

Powered by

All the data and insights you need on Inovio Pharmaceuticals Inc in one report.

$195 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Inovio Pharmaceuticals Inc Strategy Report

  • Understand Inovio Pharmaceuticals Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Inovio Pharmaceuticals Inc: Executives

Select Item

The following section provides information on Inovio Pharmaceuticals Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Inovio Pharmaceuticals Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Simon X. Benito

Chairman Executive Board Since: 2019 Age: 78

Mr. Simon X. Benito has been the Chairman of the company since 2019. Prior to this, he served as the Director of Inovio since 2003. Mr. Benito held various leadership positions at Merck & Co. including Senior Vice President of Merck Vaccine Division and Vice President of Merck Human Health for Japan. Mr. Benito also served as Executive Vice President of Merck-Medco Managed Care.

Read Hide full bio of Simon X. Benito

Jacqueline E. Shea, Ph.D.

Director; Chief Executive Officer; President Executive Board Since: 2022

Ms. Jacqueline E. Shea has been the President, Director and Chief Executive Officer of the company since 2022. Prior to this she served as a Chief Operating Officer of the company from March 2019 to May 2022. Prior to this, she was the Chief Executive Officer of Aeras. Ms. Shea also served as the Chief Operating Officer of Aeras, General Manager and Vice President of The Oxford-Emergent Tuberculosis Consortium at Emergent BioSolutions.

Read Hide full bio of Jacqueline E. Shea, Ph.D.

Peter D. Kies

Chief Financial Officer Senior Management Since: 2002 Age: 59

Mr. Peter D. Kies has been the Chief Financial Officer of the company since 2002. Prior to this, he served as the Chief Financial Officer at Newgen Results Corporation. Mr. Kies held various financial positions at Cytel Corporation and Ernst & Young, LLP.

Read Hide full bio of Peter D. Kies

Michael Sumner

Chief Medical Officer Senior Management Since: 2022

Mr. Michael Sumner has been the Chief Medical Officer of the company since June 2022. Prior to this he served as a Chief Medical Officer at Orexo AB from 2013 to 2022. Previously he held Novartis Pharmaceuticals, Aventis Behring, Novo Nordisk and Shire Pharmaceuticals.

Read Hide full bio of Michael Sumner

Laurent Humeau, Ph.D.

Chief Scientific Officer Senior Management Since: 2019 Age: 56

Mr. Laurent Humeau has been the Chief Scientific Officer of the company since March 2019. Prior to this, he served as the Senior Director of Translational Research, Human Therapeutics Division for Intrexon. Mr. Humeau also served as the Chief Scientific Officer, Vice President of R&D at VIRxSYS Corporation.

Read Hide full bio of Laurent Humeau, Ph.D.
Gain a 360-degree view of Inovio Pharmaceuticals Inc and make more informed decisions for your business Gain a 360-degree view of Inovio Pharmaceuticals Inc and make more informed decisions for your business Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward